Drug recall · March 13, 2013
ABILIFY recall
Why: CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
- Lots / codes
2E69023A, Exp. FEB 28 2015
- Quantity
- 21 blister packs
- Company
- Bristol Myers Squibb Manufacturing Company, Humacao, PR
- Distribution
- LA, TN, CA
- Initiated
- November 2, 2012 · Voluntary: Firm initiated
- Classified
- March 4, 2013
- Reported
- March 13, 2013
- Ended
- May 2, 2013
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Abilify
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.